Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Biotechnol ; 101(3): 229-39, 2003 Mar 20.
Artigo em Inglês | MEDLINE | ID: mdl-12615392

RESUMO

The large-scale production of recombinant biotherapeutics, particularly recombinant proteins, provides significant process and regulatory challenges to the biotechnology industry in order to meet the regulatory agencies stringent requirements in a cost-effective manner. Host cell derived nucleic acid causes problems from both a process and a regulatory perspective, as high molecular weight chromosomal DNA is responsible both for the viscosity of cell lysates, and it is a source of heterologous DNA sequences whose inclusion in the final product must be prevented. We have constructed a modified Escherichia coli JM107 expression host (JMN), containing a staphylococcal nuclease expression cassette, integrated into the host chromosome at the dif locus. The nuclease is expressed as a fusion to the ompA signal peptide, and is translocated to the periplasm of the cell, protecting the cytoplasmic nucleic acid from any toxic activity. The nuclease is released during cell lysis, where it subsequently acts to hydrolyse host nucleic acid present in the lysate. Results with this strain show that sufficient levels of nuclease activity are produced to completely auto-hydrolyse the host's chromosomal DNA to a size non-visible on 1% agarose gel, generating a markedly lower lysate viscosity. This provides a suitable methodology to remove heterologous DNA sequences early in the product stream and decrease lysate viscosity, improving the efficiency of downstream processing and product yield, whilst avoiding the addition of exogenous nuclease and its prohibitive costs at large-scale.


Assuntos
Escherichia coli/genética , Escherichia coli/metabolismo , Regulação da Expressão Gênica , Nuclease do Micrococo/biossíntese , Transfecção/métodos , Sequência de Bases , Clonagem Molecular , DNA Bacteriano/genética , DNA Bacteriano/metabolismo , Hidrólise , Nuclease do Micrococo/genética , Nuclease do Micrococo/metabolismo , Dados de Sequência Molecular , Proteínas Recombinantes de Fusão/biossíntese , Staphylococcus aureus/enzimologia , Staphylococcus aureus/genética
2.
Nucleic Acids Res ; 30(4): 1046-55, 2002 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-11842117

RESUMO

Active partitioning of low-copy number plasmids requires two proteins belonging to the ParA and ParB families and a cis-acting site which ParB acts upon. Active separation of clusters of plasmid molecules to the defined locations in the cell before cell division ensures stable inheritance of the plasmids. The central control operon of IncP-1 plasmids codes for regulatory proteins involved in the global transcriptional control of operons for vegetative replication, stable maintenance and conjugative transfer. Two of these proteins, IncC and KorB, also play a role in active partitioning, as the ParA and ParB homologues, respectively. Here we describe mapping the regions in KorB responsible for four of its different functions: dimerisation, DNA binding, repression of transcription and interaction with IncC. For DNA binding, amino acids E151 to T218 are essential, while repression depends not only on DNA binding but, additionally, on the adjacent region amino acids T218 to R255. The C-terminus of KorB is the main dimerisation domain but a secondary oligomerisation region is located centrally in the region from amino acid I174 to T218. Using three different methods (potentiation of transcriptional repression, potentiation of DNA binding and activation in the yeast two-hybrid system) we identify this region as also responsible for interactions with IncC. This IncC-KorB contact differs in location from the ParA-ParB/SopA-SopB interactions in P1/F but is similar to these systems in lying close to a masked oligomerisation determinant.


Assuntos
Proteínas de Bactérias/química , Proteínas de Bactérias/fisiologia , Plasmídeos , Sequência de Aminoácidos , Proteínas de Bactérias/genética , Reagentes de Ligações Cruzadas/química , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/fisiologia , Dimerização , Glutaral/química , Dados de Sequência Molecular , Estrutura Terciária de Proteína , Proteínas Repressoras/genética , Proteínas Repressoras/fisiologia , Deleção de Sequência , Homologia de Sequência de Aminoácidos , Técnicas do Sistema de Duplo-Híbrido
3.
J Biotechnol ; 85(3): 297-304, 2001 Feb 23.
Artigo em Inglês | MEDLINE | ID: mdl-11173096

RESUMO

Regulatory agencies have stringent requirements for the large-scale production of biotherapeutics. One of the difficulties associated with the manufacture of plasmid DNA for gene therapy is the removal of the host cell-related impurity RNA following cell lysis. We have constructed a modified Escherichia coli JM107 plasmid host (JMRNaseA), containing a bovine pancreatic ribonuclease (RNaseA) expression cassette, integrated into the host chromosome at the dif locus. The expressed RNaseA is translocated to the periplasm of the cell, and is released during primary plasmid extraction by alkaline lysis. The RNaseA protein is stable throughout incubation at high pH ( approximately 12-12.5), and subsequently acts to hydrolyse host cell RNA present in the neutralised solution following alkaline lysis. Results with this strain harbouring pUC18, and a 2.4 kb pUC18DeltalacO, show that sufficient levels of ribonuclease (RNase) activity are produced to hydrolyse the bulk of the host RNA. This provides a suitable methodology for the removal of RNA, whilst avoiding the addition of exogenous animal sourced RNase and its associated regulatory requirements.


Assuntos
Escherichia coli/enzimologia , Escherichia coli/genética , Plasmídeos/isolamento & purificação , Ribonuclease Pancreático/genética , Animais , Biotecnologia , Bovinos , Divisão Celular , DNA Bacteriano/isolamento & purificação , DNA Recombinante/genética , DNA Recombinante/isolamento & purificação , Contaminação de Medicamentos , Escherichia coli/química , Expressão Gênica , Terapia Genética , Plasmídeos/genética , RNA Bacteriano/isolamento & purificação , Ribonuclease Pancreático/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA